---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-177426"
form_type: "8-K"
ticker: "ACH"
cik: "0000075252"
company_name: "ACCENDRA HEALTH INC/VA/"
filed_at: "2025-08-11T23:59:59+00:00"
generated_at: "2026-05-17T15:54:18.648483+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Owens & Minor Q2: GAAP loss from continuing ops $83.8M; Products & Healthcare segment classified as discontinued ops

## Summary
- Revenue from continuing ops $681.9M, up 3% YoY from $660.4M.
- GAAP loss from continuing ops $(83.8)M vs $(6.7)M in 2Q24; adjusted net income $20.5M vs $19.3M.
- Adjusted EBITDA from continuing ops $96.6M, up 6% from $91.1M.
- Company in final stages of divestiture of Products & Healthcare Services segment; classified as discontinued ops.
- 2025 continuing ops financial outlook to be provided during 8:30 a.m. EDT earnings call.

## SEC filing metadata
- accession: 0001193125-25-177426
- form_type: 8-K
- ticker: ACH
- cik: 0000075252
- company_name: ACCENDRA HEALTH INC/VA/
- filed_at: 2025-08-11T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/75252/000119312525177426/0001193125-25-177426-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/75252/000119312525177426/d47157d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-177426
- JSON: https://secwatch.observer/filing/0001193125-25-177426.json
- Plain text: https://secwatch.observer/filing/0001193125-25-177426.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.